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Abstract
Recent reports suggested that Delta1, 4 and Jagged1, 2 possessed the ability to instruct CD4
+ T cell into selection of Th1 or
Th2 fates, respectively, although the underlying mechanism endowing the cleaved Notch receptor with memory of ligand
involved in its activation remains elusive. To examine this, we prepared artificial antigen-presenting cells expressing either
DLL1 or Jag1. Although both ligands were efficient in inducing Notch2 cleavage and activation in CD4
+ T or reporter cells,
the presence of Lunatic Fringe in CD4
+ T cells inhibited Jag1 activation of Notch1 receptor. Neither ligand could induce Th1
or Th2 fate choice independently of cytokines or redirect cytokine-driven Th1 or Th2 development. Instead, we find that
Notch ligands only augment cytokine production during T cell differentiation in the presence of polarizing IL-12 and IL-4.
Moreover, the differentiation choices of naı ¨ve CD4
+ T cells lacking c-secretase, RBP-J, or both in response to polarizing
cytokines revealed that neither presenilin proteins nor RBP-J were required for cytokine-induced Th1/Th2 fate selection.
However, presenilins facilitate cellular proliferation and cytokine secretion in an RBP-J (and thus, Notch) independent
manner. The controversies surrounding the role of Notch and presenilins in Th1/Th2 polarization may reflect their role as
genetic modifiers of T-helper cells differentiation.
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Introduction
Naive CD4
+ T cells can acquire at least four distinct phenotypes
following activation by antigen, including three distinct types of
effectors, Th1, Th2 and Th17 cells and various subsets of
regulatory T cells [1,2,3,4,5,6,7]. Among the factors that influence
the choice of the naı ¨ve T cells toward these distinct fates, cytokines
produced by antigen presenting cells (APCs) exert powerful effects
that promote or restrict these choices [4,8,9,10,11,12]. Of the
cytokines that regulate CD4
+ T cell development, interferon-c
(IFN-c) and IL-12 promote Th1 development, IL-4 promotes Th2
development, and in their absence, the cytokines IL-6 and TGF-b
induce Th17 development. Cytokine-induced regulation of Th1,
Th2 and Th17 development is mediated through the transcription
factors T-bet [13,14,15], GATA-3 [16,17,18,19,20] and RORct
[21], respectively. In addition to cytokine signaling pathways,
many other factors have been proposed to regulate these choices
[6,22,23,24,25,26,27,28].
Recent studies have suggested that distinct Notch ligands
expressed on APCs might regulate Th1 and Th2 fate choice
[29,30,31,32]. Notch proteins are membrane-bound receptors that
regulate diverse cell fate decisions in multi-cellular organisms [33].
Notch signaling regulates developmental processes during hema-
topoiesis and lymphopoiesis, and is essential for differentiation of
single-positive T-cells from the common lymphoid progenitor
[34,35,36,37,38,39,40]. Despite the assumption that manipulation
of this linear pathway by different strategies should lead to a
similar set of observations, the role of Notch signaling in Th1 and
Th2 development has been controversial (Table S1A & B) [29].
Particularly provocative were reports that DLL1 biased naı ¨ve
CD4
+ T cells towards the Th1 fate [31], whereas Jag1 biased
toward Th2 [30], suggesting that pathogens drive distinct T helper
fate choices through the induction of alternative Notch ligands on
antigen presenting cells [30].
While the induction of Th1 or Th2 development by distinct
Notch ligands might resemble the mechanism of fate induction
mediated by cytokines such as IL-12 and IL-4, it is difficult to
explain how activation of Notch receptors by its ligands could
instruct divergent fates. Understanding this difficulty requires an
appreciation of how Notch is activated: binding of DLL1 or Jag1
ligands to the Notch extra-cellular domain triggers a conforma-
tional change that exposes a b-strand of Notch to cleavage by
ADAM family metalloproteases [41,42]. This cleavage results in
shedding of the ectodomain [43,44], generating an intermediate
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secretase. Nicastrin then transfers truncated Notch into the active
site of c-secretase, which cleaves the Notch transmembrane
domain near the inner leaflet [46,47]. Following this cleavage, the
Notch intracellular domain (NICD) translocates to the nucleus
where it regulates gene expression [47,48]. The four mammalian
Notch receptors regulate transcription through a common DNA
binding protein, RBP-J [49], and require the recruitment of
mastermind-like (MAML) proteins [50,51,52,53] and additional
co-activators [54,55] to initiate transcription on target promoters.
Given this activation mechanism, it is unclear how NICD could
retain the memory of which ligand induced ectodomain shedding
and translate this memory into distinct transcription profiles.
Therefore, it is immensely interesting to explore the basis of such
‘‘ligand memory’’ and to explain how DLL1 could induce Th1
through T-bet upregulation [31], whereas Jag1 could initiate Th2
development by inducing GATA-3/IL-4 expression [30,56,57],
when both ligands should lead to essentially the same intracellular
signal within the T cells.
We examined the activity of Notch ligands in directing Th1/
Th2 differentiation. In contrast to previous reports [30,31], we
demonstrate that DLL1 and Jag1 are insufficient for instructing
specification of either Th1 or Th2 fates in the absence of
polarizing cytokines, and can mildly enhance cytokine-induced
Th1/Th2 responses. In addition, we show for the first time that
Jag1 is incapable of activating Notch1 signaling in naı ¨ve CD4
+ T
cells, which express Lunatic Fringe. We also examined the
requirement for Notch signaling on CD4
+ T cell fate specification
by removal of Presenilin1 (PS-1) and PS-2 genes, which encode the
c-secretase catalytic subunits, and by removal of the nuclear Notch
co-activator RBP-J, to separate Notch-independent from Notch
dependent activities of c-secretase.
First, we find that Notch signaling is not necessary for cytokine-
induced Th1/Th2 fate selection, consistent with some previous
studies that identified a co-stimulatory role for Notch [58,59,60].
This analysis, however, uncovered two novel, RBP-J-independent
functions of presenilin, one contributing to the proliferative
response and the other to secretion of cytokines in T-helper cells.
Taken together, our data suggest that intact Notch signaling and
Presenilins function permit optimal peripheral T-helper cell
responses, rather than exerting direct influences on Th1/Th2
differentiation choices.
Materials and Methods
Mice
All animal were housed and all experiments were conducted
according to the IACUC guidelines and approved by the
Washington University Animal Studies Committee. BALB/c
(Charles River Labs), CD4-cre
Tg/Tg (C57BL/6; Taconic) [61],
PS1
C/C PS2
2/2 [62]; RBP-J
C/C [63] and DO11.10 TCR trans-
genic mice [64] used for the experiments in Figure 1–2, were
described before. The parental PS1
C/C PS2
2/2, maintained as
C57BL/6/CD1 hybrids, was crossed with CD4-cre
Tg/Tg and F1
offspring were backcrossed twice into PS1
C/C PS2
2/2 to obtain the
genotypes CD4-Cre
Tg/+, PS1-1
C/+, PS2
2/2 (Het)a n dCD4-Cre
Tg/+,
PS1-1
C/C, PS2
2/2 (PSdko).T h ePS1/PS2 and RBP-J triple knockout
miceweregeneratedbyfirstcrossingCD4-Cre
Tg/+,PS1-1
C/+,PS2
2/2
mice with PS1-1
C/C, PS2
2/2, RBP- J
C/C mice to generate CD4-
Cre
Tg/+, PS1-1
C/+, PS2
2/2, RBP-J
C/+ mice. These F1 offspring were
crossed again with PS1-1
C/C, PS2
2/2, RBP-J
C/C miceto produceF2
littermates with the following genotypes: CD4-Cre
Tg/+, PS1-1
C/+,
PS2
2/2, RBP-J
C/+(Het), CD4-Cre
Tg/+, PS1-1
C/C, PS2
2/2, RBP-J
C/+
(PSdko), CD4-Cre
Tg/+, PS1-1
C/+, PS2
2/2, RBP-J
C/C (Rko)a n dCD4-
Cre
Tg/+, PS1-1
C/C, PS2
2/2, RBP-J
C/C (PSRtko), which were used for
the experiments in Figure 3–6.
Plasmids and retroviral constructs
PCS2+N1DE encodes truncated Notch1 protein that is a
constitutive substrate of c-secretase [44]. TP1-luc construct
(PGa981-6) is a Notch reporter cassette that contains 12 tandem
repeats of CSL binding sites upstream of luciferase [65]. pYITG
and pCGP plasmids used for packaging retrovirus were a generous
gift from Dr. W. Sha (University of California, Berkeley, CA).
Mouse DLL1 cDNA clone (#9021250) was obtained from ATCC
(Manassas, VA) and mouse Jag1 cDNA clone (#97002RG) was
obtained from Invitrogen (Carlsbad, CA).
The primers 59-CGGGATCCGCCAATGCGGTCCCCACG-
GACGCGC-39 and 59-GTTCTCGAGCTATACGATGTATTC-
CATCCGGTT-3 were used to amplify Jagged1 cDNA. The
primers 59-GAGGATCCGCCATGGGCCGTCGGAGCGCGC-
TAG-39 and 59-TTACTCGAGTTACACCTCAGTCGCTATAA-
CAC-39 were used to amplify DLL1 cDNA. The PCR amplified
fragments were first blunt cloned into PCS2+ vectors and then
replaced with original cDNA sequences by restriction digest.
PCS2+DLL1 and PCS2+Jagged1 were then completely sequenced,
digested with BamHI and XhoI, and the ligands subcloned into the
Bgl II and XhoI site on the IRES-GFP-RV vector.
Cell lines
CHO cell lines stably expressing either full-length Notch2
(CHOfNotch2) or full-length Delta-like-1 (fD1-CHO) were a
generous gift from Drs. S. Chiba and H. Hirai (University of
Tokyo, Japan). Parental CHO cells expressing MHC class II
molecules (I-A
d haplotype) and B7-1 were a generous gift from Dr.
A. Sharpe (Harvard University, Boston, MA) and were used to
generate artificial APC lines that express Notch ligands. Retroviral
infection of CHO cells was performed with a protocol modified
from Dr. G. Nolan’s lab (Stanford University, CA). Briefly,
retrovirus was packaged by transfection of 293T cells with
constructs pYITG, pCGP and the viral vectors using the calcium
phosphate method (in BES buffered saline with chloroquine at a
final concentration of 25 mM). After 9 h, transfected 293T cells
were washed once and replenished with new media. Virion-
containing supernatant (10 ml) was harvested 48 h post-transfec-
tion, filtered (0.45 mM) and transferred to CHO cells (4.5 ml of
293T supernatant in 6.5 ml of media supplemented with
polybrene at a final concentration of 5 mg/ml). After 48 h, 6 to
25% of cells were infected. Three different GFP
hi APC lines
(IRES-GFP-RV infected or CHO-B7; DLL1-IRES-GFP-RV
infected or CHO-DLL1; Jagged1-IRES-GFP-RV infected or
CHO-Jag1) were FACS sorted to .95% purity, stained with I-
A
d and B7-1-phycoerythrin and analyzed by flow cytometry to
confirm a comparable level of staining for MHC and B7 ligands
(80–90% of the GFP
hi population; Figure S1A). All APC cells were
maintained in Iscove’s DMEM, supplemented with 10% heat-
inactivated FBS, nonessential amino acids, sodium pyruvate,
penicillin/streptomycin and b-mercaptoethanol. 293 T cells were
maintained in DMEM media according to ATCC protocol.
Co-culturing Experiment
1.2610
5 of CHOfNotch2 cells was seeded on 24-well plate 24 h
prior to transfection. PCS2+bgal (control for transfection), TP1-luc
and PCS2+ (as DNA carrier) plasmids were transfected by
Lipofectamine
TM 2000 according to manufacturer protocol.
Artifical APC lines or fD1-CHO (positive control, at 0.1610
6)
were added 24 hr after the transfection and luciferase assay was
carried out 48 h later.
Th Fates Are Notch Independent
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Cells were harvested after 48 h in co-culture and washed once
with phosphate-buffered saline (PBS). Cells were lysed in 100 mlo f
lysis buffer (100 mM KPO4 buffer, pH 7.8; 0.2% Triton; 1 mM
dithiothreitol (DTT); protease inhibitors) at room temperature for
10 min. 5 ml of lysate was used to determine b-galactosidase
concentration (to normalize for transfection efficiency) according
to the Tropix Galacton chemiluminescent substrate instructions.
50 ml of lysate incubated with luciferin assay buffer (30 mM
Tricine, pH 7.8; 3 mM ATP; 15 mM MgSO4; 10 mM DTT;
0.2 mM CoA; 1 mM luciferin) was used to determine luciferase
activity using a Tropix TR717 luminometer.
Western Blot
Laemmli SDS sample buffer (+10 mM DTT) was added
directly to half a million naı ¨ve CD4
+ T cells and the mixture
was heated at 55uC for 10 min. Protein samples were resolved by
12% (PS1), 8% (RBP-J, Lfng, GATA-3, T-bet, b-actin) and 6%
(cleaved Notch1) SDS-PAGE gel in 25 mM Tris, 192 mM glycine,
0.1% SDS buffer. Proteins were then transferred to nitrocellulose
in 25 mM Tris, 192 mM glycine, 20% methanol buffer. Blots
were incubated with primary antibody in 0.1% Tween and 5%
milk in PBS at 4uC overnight. The primary antibodies used were
anti-b-actin at 1:5000 dilution (Sigma, A5441); anti-V1744 at
1:500 (Cell signaling, #2421); anti-RBP-J at 1:100 (Cosmobio,
SIM-2ZRBP2); anti-PS1 at 1:1000 (sc-7860); anti-Lfng (sc-8239) at
1:1000; anti-T-bet (sc-21749) at 1:200; and anti-GATA-3 (sc-268)
at 1:200 (all from Santa Cruz). After three washes, the membranes
were incubated with secondary antibody diluted 1:5000 in 0.1%
Tween PBS for 1 h at room temperature. The secondary
antibodies used were anti-mouse (Amersham, NA931), anti-rabbit
(Amersham, NA934) or anti-goat (Santa Cruz, sc-2020) IgG,
Figure 1. Functional Notch ligands on APCs do not affect APC-mediated T cell proliferation. (A) Schematic of the experiment. Artificial
APC lines were treated with mitomycin C (100 mg/ml for 1 h) and seeded either for co-culture reporter assay or for activating naı ¨ve CD4
+ T cells
isolated from DO11.10 mice. Irradiated BALB/c spleen cells were used as the natural APC control. Activated CD4
+ T cells were assayed for the rate of
proliferation, level of IFNc and IL-4 production under the 4 polarizing conditions, and the presence of activated Notch1 and Lfng proteins. (B) The
Notch ligands expressed on APC lines elicit Notch2 cleavage and RBP-J-dependent transcriptional activation of TP1-luciferase in co-culture system.
Results are mean6S.D. of three independent experiments. (C) Functional Notch ligands on APC lines do not affect T cell proliferation. Naı ¨ve CD4
+ T
cells purified from DO11.10 mice were cultured with the different APC lines under various concentrations of OVA peptide, as indicated on the
horizontal axis. The cultures were pulsed with [
3H] thymidine at 48 h, harvested and analyzed at 60 h. Data represent c.p.m6s.d. from triplicate wells.
doi:10.1371/journal.pone.0002823.g001
Th Fates Are Notch Independent
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stimulation. (A) Notch ligands cannot induce a Th1 program under ‘‘drift’’ or ‘‘neutral’’ conditions, whereas only DLL-1 enhances IFN-c production
under Th1 polarizing conditions. Naı ¨ve CD4
+ T cells from DO11.10 mice were purified to .99% purity by a two-step protocol, and primed with
different APC lines and 0.3 mM OVA peptide in 4 polarizing conditions for 2 days. Activated T cells were expanded in fresh media for another 5 days,
re-stimulated with 4 h of PMA/Ionomycin and stained for intracellular IFN-c. B7: CHO-B7, DLL1: CHO-DLL1, J1: CHO-Jag1 and Spl: BALB/c spleen cells.
Th Fates Are Notch Independent
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three rinses, the protein was visualized with Super-Signal H West
Pico/Dura/Femto Chemiluminescent kit (Pierce) as per the
Hyperfilm
TM MP instructions (Amersham Biosciences).
T cell purification and in vitro differentiation
Naı ¨ve CD4
+ T cells Purification
Two different methods were used in this study. The first
method, used to generate Figure 3B, employed MACS column
and anti-CD4 magnetic beads (Miltenyi Biotech, Auburn, CA) for
rapid separation of CD4
+ T cells. For other experiments in this
study, a two-step purification protocol was used. The CD19+
fraction was first removed with anti-CD19 magnetic beads on
MACS column (Miltenyi Biotech, Auburn, CA). Subsequently, the
CD19-negative fraction was FACS sorted (MoFlo
TM, Dako) using
CD4-FITC (Caltag, RM2501) and CD62L-phycoerythrin anti-
bodies (Caltag, RM4304) to purify CD4
hi, CD62L
hi population.
Priming by APC
2610
6 artificial APC cell lines were seeded on a 60-mm culture
plate one day prior to the experiment. On the day of the
experiment, APC cells were treated with 100 mg/ml of mitomycin
C (Sigma) at 37uC for 1 h, washed twice in PBS and lifted with
0.2 M EDTA. APCs were then seeded (at 0.25610
6) on 48-well
plates (for subsequent activation of T cells) or added (at 0.1610
6)
to transfected CHOfNotch2 (for reporter assay). To control for the
activity of natural APCs, 5610
6 irradiated (2000 Rad) splenocytes
from BALB/c mice (spl) were used. 0.5610
6 naı ¨ve CD4+ T cells
isolated to .98% purity from DO 11.10 mice were added to the
0.25610
6 APCs in the presence of 0.3 mM OVA peptide and
under one of the 4 polarizing conditions. Th1: 10 U/ml of IL-12
and 10 mg/ml of anti-IL-4 (11B11). Th2: 100 U/ml of IL-4,
3 mg/ml of anti-IL-12 (TOSH) and 10 mg/ml of anti-IFNc (H22).
Drift: Only media. Neutral: 10 mg/ml of anti-IL-4 (11B11),
3 mg/ml of anti-IL-12 (TOSH) and 10 mg/ml of anti-IFNc (H22).
Polarization experiments were carried out in a 7-day cycle, starting
with activation on day 0. On day 2, cells were expanded into fresh
media containing 40 U/ml of IL-2 (see Table S4A for additional
details). T cells were collected on day 7 and counted. 0.5610
6 T
cells were then re-stimulated either with plate-bound anti-CD3 for
24 h and its supernatant collected for ELISA, or PMA (50 ng/ml)
and Ionomycin (1 mM) in the presence of Brefeldin A (1 mg/ml,
Epicenter Technology, Epicenter Technologies, Madison, WI) for
the 4 h and subjected to intracellular cytokine staining.
Priming by anti-CD3/anti-CD28
48 well plates were coated with anti-CD3 (500A2: 1 mg/ml) and
anti-CD28 (0.8 mg/ml) overnight at 4uC. 0.5610
6 of purified
naı ¨ve CD4
+ T cells (.95%) from different genotypes (Het, PSdko,
Rko & PSRtko) were stimulated in 6-day cycles, starting with
activation on day 0 in either Th1 or Th2 polarizing conditions (see
below). On day 2, cells were expanded into fresh media plus
40 U/ml of IL-2 (see Table S4B and C for details) and resting cells
were collected on day 6/7 and counted. 0.5610
6 of cells from each
genotype were re-stimulated overnight with plate-bound anti-CD3
or PMA (50 ng/ml) and Ionomycin (1 mM). Brefeldin A (1 mg/ml;
Epicentre Technology) was added for the final 4 h of each
stimulation. Cells were subjected to intracellular cytokine staining
and supernatant collected for ELISA.
Proliferation Assay
0.1610
6 purified T cells were plated onto a 96-well plate seeded
with an equal number of APC lines (Figure 1C & Figure S1C) or
pre-coated with anti-CD3/CD28 antibodies (Figure 3C) in 100 ml
media. After 48 h, cells were pulsed for 12 h with 1 mCi/well of
[
3H]-thymidine.
Intracellular cytokine staining, ELISA and FACS analysis
After re-stimulation, the cells harvested were resuspended in
FACS buffer (3% FCS in PBS, 0.01% azide). Cells were stained with
phycoerythrin (PE)-cy7 conjugated anti-CD4 antibody (552775, BD
Bioscience Pharmingen
TM, San Diego, CA) and fixed in 2%
formaldehyde for 15 min at room temperature. After washing once
with PBS, cells were permeabilized twice with saponin (0.05%
followed by 0.5% in FACS buffer). The cells were stained with
respective antibodies in 0.5% saponin at 4uC for 30 min. Isotype
control and cytokine antibodies used were from BD Bioscience
Pharmingen
TM(SanDiego,CA). ThePE-conjugated antibodiesare:
anti-IL4 (554389), anti-IFNc (554412), Rat IgG1k (554685) and Rat
IgG2bk (556925). The APC-conjugated antibodies are: anti-IL4
(554436), anti-IFNc (554413) and Rat IgG1k (554686). Cells were
then washed once and resuspended in FACS buffer for analyses.
ELISA (enzyme-linked immunosorbent assay) was carried out with
mouse Th1/Th2 cytokine cytometric bead array according to
manufacturer’s protocol (BD Bioscience, San Diego, CA) and
analyzed on a FACSCaliber (Becton Dickinson, San Jose, CA).
Tabulation of cytokine production
Ten independent in vitro polarization experiments were
conducted for Figures 4–6, comprising of at least one control
(Het) and two test genotypes (PSdko, Rko or PSRtko) per experiment.
The level of secreted cytokines was measured empirically. In each
experiment, the highest secreted cytokine level was set as 100%
and used to normalize the values from other genotypes. Results
from the independent experiments were compiled with these
percentiles and presented as relative cytokine level. The normality
of distribution and significance were calculated by Kolmogorov-
Smirnov and two-tailed paired t-test respectively.
Results
Notch ligands expressed by APCs are functional and do
not alter T cell proliferation
Based on in vitro differentiation assays of naı ¨ve CD4
+ T cells, an
inductive role for Notch in promoting Th1 or Th2 development
was recently suggested [30]. To test how Notch signals could
Results are mean6s.d. from three independent experiments. (B) DLL1 and Jag1 ligands do not cause significant differences in the level of IL-4
production under ‘‘drift’’ and ‘‘neutral’’ conditions. They only marginally enhance IL-4 cytokine secretion under Th2 polarizing conditions. Activated T
cells were re-stimulated on Day 7 with anti-CD3 antibody for 24 h and before supernatant collection and ELISA. Results are mean6s.d. of three
independent experiments. The P value was determined by student two-tailed t test. (C) Only CHO-DLL1 APC line triggers Notch1 cleavage in activated
CD4
+ T cells. Naı ¨ve CD4
+ T cells from DO10.11 mice were purified to .99% purity by the two-step protocol and primed with various APC lines and
0.3 mM OVA peptide in 3 different polarizing conditions. They were isolated 24 h later and probed with V1774 and actin antibodies. WB: western blot.
(D) Detection of Lunatic Fringe in CD4
+ T cells. Naı ¨ve CD4
+ T cells purified from DO11.10 mice were activated with anti-CD3/CD28 antibodies under
the 4 polarizing conditions for 24 h and harvested for western with anti-Lfng antibody. Lysate from newborn pup (P1) was used as positive control
whereas negative control was lysate from NIH3T3 cells. WB: western blot.
doi:10.1371/journal.pone.0002823.g002
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alleles by CD4-cre transgene. Naı ¨ve CD4
+ T cells isolated from conditional knockout littermates (n$7 animals per genotype) showed no detectable
level of RBP-J and presenilin1 proteins. WB: western blot. (B) Removal of PS1/PS2 proteins abolished Notch1 signaling in activated naı ¨ve CD4
+ T cells.
Activated Notch1 is detected in activated control CD4
+ T cells under both Th1 and Th2 polarizing conditions but not detected in T cells that have
targeted ablation of PS1/PS2 alleles. Non transfected HEK293T cells were used as negative control, while cells transfected with PCS2+N1DE was used
as a positive control. CD4
+ T cells were isolated with anti-CD4 magnetic beads on MACS column to .95% purity from the spleens of 2 months old
littermates. This protocol allows co-purification of natural APCs that provide the Notch ligands (compare with Figure 2C where no Notch1 activation
was observed when a two-step purification method was used). T cells were activated with anti-CD3/CD28 in Th1 or Th2 polarizing conditions for 24 h.
T cells were then FACS sorted for CD4
+ population and probed with V1744 antibody. WB: western blot. (C) Proliferation capacity was measured by
3[H]-thymidine incorporation. Reduced proliferation was observed in PSdko and PSRtko cells under both Th1 and Th2 polarizing conditions. Rko cells
were not significantly different than controls. Results are presented as mean6S.D. of five wells and representative of at least three independent
experiments. (D, E) Reduction in the final number of viable PSdko and PSRtko T cells 6 days after activation. Naı ¨ve CD4
+ T cells from different
genotypes were stimulated with anti-CD3/CD28 antibodies for 2 days in Th1 and Th2 conditions before they were expanded in fresh media
containing IL-2 cytokine. After 6 days of culture, T cells were harvested and viable cells were counted. Each circle/diamond indicates data of individual
mouse. In Figures 1–4, circle (#) indicates data point in which CD4
+ T cells were expanded by regimen 2 (Supplemental Table 4B), whereas diamond
(e) indicates result in which T cells were expanded according to regimen 3 (Supplemental Table 4C). The P value was determined by student two-
tailed t test. (F, G) The expression of T-bet and GATA-3 is unaffected by the removal of RBP-J and/or presenilins. T cells activated in Th1 or Th2
conditions were harvested and probed with T-bet or GATA-3 antibodies after 6 days in culture. Results are representative of three independent
experiments. WB: western blot.
doi:10.1371/journal.pone.0002823.g003
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Notch-ligand expressing APCs by modifying Chinese hamster
ovary (CHO) cells that stably express B7-1 and MHC class II (I-
A
d) to also express either DLL1 or Jag1 ligands (Figure 1A and
Figure S1A). To confirm the effectiveness of Notch ligands
expressed by these APCs, we co-cultured our panel of APC lines
with CHOfNotch2 reporter cells that express a full-length Notch2
receptor [66] and the TP-1 luciferase reporter cassette [65]. We
found that the APCs that express DLL1 or Jag1 could robustly
stimulate luciferase activity in CHOfNotch2 cells. In contrast, the
APC line CHO-B7, which contains GFP-expressing retroviral
vector and lacks Notch ligands, failed to induce luciferase activity
in CHOfNotch2 cells (Figure 1B). These results are an important
positive control demonstrating the functional integrity of the
DLL1 and Jag1 ligands expressed by our APCs.
Given that attaining optimal T-helper differentiation requires
proliferation [67,68,69,70], we tested the proliferative responses of
naı ¨ve CD4
+ T cells activated by APCs with or without Notch
ligands. To inhibit APC proliferation, APC were exposed to 1 hr
of 100 mg/ml mitomycin C treatment. This regimen effectively
blocked APC proliferation; allowed Notch ligands on the APC
lines to induce luciferase activity in CHOfNotch2reporter lines
(Figure 1B); and triggered proliferative responses in naı ¨ve
Figure 4. RBP-J and presenilins are not required for the
production of intracellular IFN-c in CD4
+ T cells activated under
Th1 polarizing conditions. (A, B) Production of intracellular INF-c is
unaffected in different mutant genotypes in Th1 polarizing conditions
when compared to Th2 polarizing conditions. Elevated levels of IFN-c
production are detected by ICS in RBP-J-deficient cells under Th1
polarizingconditionsafterre-stimulationwithanti-CD3butnotwithPMA/
Ionomycin. Naı ¨ve CD4
+ T cells from different genotypes were stimulated
with anti-CD3/CD28 antibodies for 2 days in Th1 and Th2 conditions. Cells
werethenexpandedintonewmedia containingIL-2cytokine.Tcellswere
harvested and counted after 6 days of culture. An equal number of T cells
were re-stimulated overnight with (A) anti-CD3 antibody, or (B) PMA/
Ionomycin. Brefeldin A was added in the final 4 h of stimulation before
intracellular staining. Each circle/diamond represents data of individual
mouse. The P value was determined by two-tailed t test.
doi:10.1371/journal.pone.0002823.g004
Figure 5. RBP-J-independent function of presenilin is required
for optimal IFN-c secretion from differentiated Th1 cells. (A, B)
Impaired IFNc cytokine production by PS1/PS2-deficient T cells is not
rescued by the compound loss of RBP-J. The experiments were
conducted as described in Figure 4 except that the supernatant was
harvested for ELISA analyses. Each data point indicates individual
mouse and is presented as the relative level of IFN-c secretion. This
value is determined by calculating the percent of IFN-c secretion from
individual mouse over the maximum level attained in each separate
experiment (see Materials and Methods for details). The P value was
determined by two-tailed paired t test.
doi:10.1371/journal.pone.0002823.g005
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+ T exposed to three different concentrations of
OVA peptide (Figure 1C). These results indicated that activation
of Notch by APCs in the presence of CD28 co-stimulation did not
enhance antigen-driven T cell proliferation. More importantly,
this system provides us with the ability to test whether functional
Notch ligands on APCs can instruct Th1 or Th2 fate selection.
Functional Notch ligands expressed by APCs do not
instruct T cell differentiation
To examine the role of Notch ligands on T cell differentiation,
naı ¨ve DO11.10 CD4
+ T cells were activated with these three APC
cell lines under 4 conditions (Figure 1A). We included both Th1-
and Th2-polarizing conditions to test if either ligand could
augment or inhibit cytokine-driven differentiation. We also
included two kinds of non-polarizing conditions to test if Notch
ligands themselves were sufficient to bias/instruct differentiation:
in one, cytokines are neither added nor neutralized to test whether
Notch ligands can bias toward Th1 or Th2 differentiation. If they
could induce IL4, for example, this condition will allow for auto-
stimulation. In the second type of non-polarizing condition,
polarizing cytokines are neutralized to test whether Notch ligands
can induce Th1 or Th2 fate acquisition on their own. Finally, we
used irradiated BALB/c splenocytes as APCs under all conditions
as a positive control for normal cytokine-induced Th1 and Th2
differentiation.
Activated T cells were passage 7 days (detailed in Table S4A),
harvested and counted. Equal number of viable cells was re-
stimulated with PMA/ionomycin (4 h in the presence of BFA for
intracellular staining) or anti-CD3 (for ELISA of the supernatant).
Artificial APC lines induced T cells expansion 2 to 3.6 fold greater
than irradiated splenocytes under all conditions (Figure S1C).
These results indicated that our APC lines are comparable to (if
not better than) natural APCs in priming naı ¨ve CD4
+ T cells.
Under Th1 polarizing conditions, we found high levels of
intracellular IFN-c production in CD4
+ T cells stimulated with
any APC line, regardless of Notch ligand expression (Figure 2A;
individual data points were depicted in Figure S2A-C & Table
S2A). CD4
+ T cells primed with splenocytes as APCs produced the
highest percentage of IFNc-positive cells detected by intracellular
staining (ICS) (78%), closely followed by T cells primed with
CHO-DLL1 (64%; P=0.006) and by CHO-B7 or CHO-Jag1
(47–48%). Similar results were observed when secreted IFN-c was
measured by ELISA of the supernatant (detailed in Table S2B).
Likewise, under Th2 polarizing conditions, high levels of IL-4
were produced by CD4
+ T cells stimulated with any APC line,
regardless of Notch ligand expression (Figure 2B, detailed in Table
S3B). CD4
+ T cells primed with CHO-DLL1 and CHO-Jag1
secreted slightly higher amounts of IL-4 compared to the CHO-B7
APC line or splenocytes. These results indicate that Notch ligands
can augment cytokine-induced Th1 or Th2 differentiation but
cannot interfere with this specification process. In particular,
DLL1, suggested to induce Th1 development [30,31], did not re-
direct T cells toward a Th1 fate under Th2-polarizing conditions.
Likewise, Jag1, suggested to induce Th2 development [30], did not
re-direct T cells toward a Th2 fate under Th1-polarizing
conditions.
Next we examined non-polarizing conditions of activation.
Surprisingly, neither DLL1 nor Jag1 had a significant effect on
Th1 or Th2 development under either of the non-polarizing
conditions compared to the CHO-B7 APC line (Figure 2A, B, and
Table S2, 3). When cytokines were neither added nor neutralized,
DLL1 expression by APCs did not cause a significant increase in
IFN-c production, as would have been predicted from a previous
study [30,31]. Similarly, Jag1 expression on APCs did not increase
IL-4 production, apparently excluding a role for Notch ligands in
biasing Th1/Th2 fate choice. Finally, under conditions where
polarizing cytokines were neutralized, neither DLL1 nor Jag1 led
to significant changes in IFN-c or IL-4 production (Figure 2A, B),
indicating that these ligands are not sufficient for driving Th1 or
Th2 fate choice. These data are inconsistent with the results
reported for DLL1 and Jag1 expression on DCEK hi7 fibroblasts
as artificial APCs [30], which claimed DLL1 and Jag1 to induce
Th1 and Th2 development, respectively. Thus, our results would
appear to exclude an instructive role for Notch ligands in inducing
actual Th1/Th2 development from naı ¨ve CD4
+ T cells.
The inability of Notch ligands expressed by our APC lines to
induce Th1 or Th2 differentiation could have resulted from their
inability to activate Notch signaling in naı ¨ve CD4
+ T cells, despite
their demonstrated activity in reporter cells (Figure 1B). Thus, we
tested if Notch1 activation occurred in naı ¨ve CD4
+ T cells co-
Figure 6. Reduced level of IL-4 secretion from PS1/PS2 and not
RBP-J deficient Th2 cells. (A, B) PS1/PS2-deficient T cells have
significant reduction in IL-4 cytokine production when compared to
RBP-J-deficient T cells independent of the mode of re-stimulation. The
experiments were conducted as described in Figures 5. Data is
presented as the relative level of IL-4, determined by comparing the
IL-4 secretion from individual mouse over the maximum level attained
in each separate experiment. The P value was determined by two-tailed
paired t test.
doi:10.1371/journal.pone.0002823.g006
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directly measuring the production of NICD1. We found that
robust Notch1 activation was induced in CD4
+ T cells by CHO-
DLL1, but not by the CHO-B7 cell line, as expected (Figure 2C).
However, we found no evidence of Notch1 activation in CD4
+ T
cells induced by CHO-Jag1 cells (Figure 2C). Lunatic Fringe
(Lfng) can modify the glycosylation pattern of Notch1 receptors
(but not Notch2) in a manner that potentiates DLL1-mediated
signaling but inhibits Jag1-mediated signaling [71,72,73]. The
inability of Jag1 to activate Notch1 in CD4
+ T cells but to activate
Notch2 signaling in a reporter line (Figure 1B) would be consistent
with Lfng activity rendering their Notch1 receptor insensitive to
activation by Jag1. To test this, we measured Lfng protein
expression by Western analysis in activated naı ¨ve CD4
+ T cells
(Figure 2D). Notably, Lfng protein was easily detected in CD4
+ T
cells under all assay conditions as well as naı ¨ve CD4
+ T cells from
different genetic backgrounds (data not shown). This result could
explain the observed lack of effect of Jag1 on Th1 differentiation.
In summary, these results confirms that Notch signaling is
activated by DLL1 in CD4
+ T cells, yet this is insufficient to
instruct either Th1 or Th2 fate specification, nor can NICD act to
redirect CD4
+ T cell differentiation under these conditions
(Figure 2).
Conditional removal of presenilin and RBP-J in CD4
+ T
cells
The results above demonstrated that Notch activation was not
sufficient to instruct T-helper cell fate selection. To test for a
genetic requirement for Notch signaling in CD4
+ T differentiation
along Th1/Th2 lineages, we used a conditional deletion approach
to eliminate all presenilin (PS) activity in CD4
+ T cells. This is
similar to the approach taken in a recent study [74], except that
different targeted PS-1 and PS-2 alleles [62] were used. Due to
strain or allele differences that may have restricted CD4-Cre
expression to the DP stage, we were able to obtain normal
numbers of CD4
+ T cells from all genotypes, in contrast to the
observations reported by Laky and Fowlkes [74]. For our analysis,
we used naı ¨ve CD4
+ T cells isolated from mice of the genotypes
CD4-Cre
Tg/+, PS1-1
C/+, PS2
2/2, RBP-J
c/+(Het); CD4-Cre
Tg/+, PS1-
1
C/C, PS2
2/2, RBP-J
c/+ (PSdko); CD4-Cre
Tg/+, PS1-1
C/+, PS2
2/2,
RBP-J
c/c (Rko)o rCD4-Cre
tg/+, and PS1-1
C/C, PS2
2/2, RBP-J
c/c
(PSRtko) (See Materials and Methods). We confirmed that
complete deletion of targeted alleles occurred in naı ¨ve CD4
+ T
cells purified from PSdko, Rko or PSRtko, lacking expression of either
PS-1 or RBP-J as expected (Figure 3A), whereas normal levels of
PS-1 or RBP-J were expressed in heterozygote littermate controls.
Next, we asked if Notch signaling is activated during the process of
T cell activation in our system. In the presence of natural APCs,
control CD4
+ T cells showed evidence of Notch1 activation 24 h
after stimulation, whereas PSdko CD4 T cells showed no
accumulation of NICD1, indicating an absence of Notch
activation (Figure 3B). These controls confirmed that Notch
signaling is active during normal T cell activation and that our
genetic manipulations have successfully eliminated Notch signaling
as intended prior to activation of CD4
+ T cell.
An RBP-J independent activity of presenilin contributes
to CD4
+ T cell expansion
We next examined the proliferative capacity of activated CD4
+
T cells under both Th1 and Th2 conditions at 48 h by H
3-
thymidine incorporation assay (Figure 3C). Over several indepen-
dent experiments, Notch ligands did not enhance proliferation in
the presence of B7 co-stimulation (Figure 1C), whereas presenilin-
deficient (PSdko) and presenlin- and RBP-J-deficient (PSRtko)T
cells consistently exhibited lower proliferation (Figure 3C). Con-
sistent with the proliferation results, cellular expansion, measured
by counting the number of viable cells 6 days after activation, was
also significantly impaired in PSdko and PSRtko populations
(Figure 3D & E). Specifically, the heterozygote Th1 cultures
showed a mean cell number of 8610
6 cells, which was reduced to
4610
6 cells in PSdko cells. The heterozygote Th2 cultures, which
showed a mean cell number of 14610
6 cells, was also reduced to
4610
6 cells in PSdko cells. A similar reduction in cellular expansion
was observed when stimulated T cells were treated with c-
secretase inhibitors [58,59]. In contrast, the deletion of RBP-J did
not significantly alter cellular expansion in T cells (Figure 3D, E),
in agreement with earlier observations [75]. Interestingly, we saw a
significant reduction in cellular expansion of triple mutant (PSRtko)
T cells lacking PS-1, PS-2 and RBP-J when compared to control T
cells from heterozygous littermates (Figure 3D and E). This result
revealed a requirement for presenilin, but not RBP-J, in T cell
expansion, consistent with a role for either a Notch-independent
function of c-secretase, or an RBP-J-independent function of
Notch. Given that Notch ligand did not alter the level of
proliferation induced by OVA peptide (Figure 1C), a Notch-
independent function of c-secretase seems most likely to be
required for optimal T cell proliferation.
We also examined the expression of the transcription factors T-
bet and GATA-3 in these cells 6 days after activation (Figure 3F
and G). Notably, we found that T-bet was expressed by all cells,
regardless of genotype (Figure 3F). In contrast, GATA-3 was
present only in T cells exposed to Th2 polarizing conditions,
regardless of their genotype (Figure 3G). The persistence of T-bet
and GATA-3 expression under Th1 or Th2 conditions indicated
that cytokine stimulation was not dependent on intact Notch
signaling. Since other methods of manipulating Notch signaling
have been reported to influence these processes in vitro
[30,31,56,57,76,77], we next turned our attention to determining
the effects of presenilin and RBP-J deficiency on Th1/Th2 fate
selection under polarizing conditions.
An RBP-J independent presenilin activity regulates the
levels of Th1 and Th2 cytokine secretion
If the Notch pathway is linear, then deletion of any one of its
components should cause the same effect as deletion of any other
component. In particular, a linear Notch pathway would predict
that deletion of RBP-J [30,75] would result in similar changes as
would Notch blockade by c-secretase inhibitors, or even by over-
expression of dominant-negative (DN) MAML [78]. However,
evidence has been accumulated that this may not be the case. In
particular, removal of RBP-J and over-expression of DN-MAML
both inhibited Th2 differentiation, but c-secretase inhibitors did
not block Th2 differentiation, and instead inhibited Th1
differentiation [77]. Because RBP-J is associated with co-repressors
in the absence of a Notch signal [79], this discrepancy was
suggested to reflect de-repression of a critical target (e.g. T-bet;
[77]). Likewise, activation of the Notch pathway has not led to the
same result. For example, over-expression of NICD1 in CD4
+ T
cells induced T-bet in some studies but not in others [31,77]. In
contrast, NICD1 induced IL-4 and GATA-3 in other studies
[30,56,57,76]. Thus, there is evidence that the effects of Notch
inhibition or activation may be context dependent, perhaps due to
the existence of a bifurcation in the pathway.
For these reasons, we compared Th1 and Th2 development in
CD4
+ T cells that lacked presenilin or RBP-J proteins (Figure 4, 5,
6). We examined the ability of these T cells to generate IFN-c by
ICS following differentiation in vitro after activation under both
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(Figure 4A) or PMA/Ionomycin treatment (Figure 4B). The
percent of IFN-c expressing cells from individual mice is shown for
each experiment as a circle or diamond, and the mean of all mice
in one group is presented as a bar. First, IFN-c is produced by T
cells only under Th1 conditions, and not under Th2 conditions,
for littermates from all genotypes. Second, the absence of
presenilin or RBP-J did not compromise the acquisition of Th1
fate (assessed as the ability to express IFN-c) under Th1
conditions, measured following re-stimulation with anti-CD3 or
with PMA/Ionomycin. In agreement with previous reports, we see
an increase in the percent of RBP-J-deficient T cells producing
IFN-c under Th1 conditions [30,75]. Thus, RBP-J-deficient CD4
+
T cells are capable of Th1 differentiation.
Although we observed a reduction in the percentage of IFN-c
positive, presenilin deficient (PSdko) T cells, this difference was not
statistically significant when compared to CD4
+ T cells isolated
from heterozygous littermates. Thus, commitment to Th1
development was still functional in CD4
+ T cells lacking presenilin
activity (Figure 4), inconsistent with the observations based on
pharmacologic inhibition of c-secretase [77]. Furthermore, PSdko
CD4
+ T cells differentiated under Th1 conditions committed to
IFN-c production at a much higher frequency than when
differentiated under Th2 conditions, demonstrating their ability
to functionally respond to Th1-inducing stimuli. No significant
difference was detected between PSRtko and heterozygous T cells,
or between PSdko and PSRtko T cells (Figure 4A, B). In summary,
as measured by ICS, cytokine-induced Th1 fate commitment does
not require the canonical Notch pathway [78].
Next we examined the ability of these T cells to secrete IFN-c
under Th1 and Th2 conditions after re-stimulating an equal
number of T cells by either anti-CD3 treatment (Figure 5A) or
PMA/Ionomycin treatment (Figure 5B). The amount of IFN-c
secretion is shown for individual mice and the mean is presented as
a horizontal bar. Generally, the results were similar to those
obtained by intracellular cytokine staining, although quantitative
differences are now evident. First, for all genotypes tested, IFN-c
secretion was always significantly higher in Th1 conditions
compared to Th2 conditions, indicating that the commitment to
Th1 development was generally intact in PSdko T cells and RBP-J-
deficient (Rko) T cells. However, the amount of IFN-c that was
secreted from PSdko T cells was reduced by about half, compared
to control T cells from heterozygous littermates (Figure 5A). In
contrast, despite an increase in the number of IFN-c positive cells
(Figure 4A), IFN-c secretion from RBP-J-deficient T cells was not
statistically different from control T cells (Figure 5A). To explain
the increase in Th1 commitment seen in RBP-J null cells, it was
proposed that de-repression of the T-bet gene occurred when RBP-
J was removed [77]. If true, removing RBP-J in presenilin-
deficient T cells (PSRtko) would de-repress T-bet and thus restore
IFN-c secretion. Instead, PSRtko T cells also exhibited a similar
reduction in IFN-c secretion to PSdko cells when compared to
control T cells, even though the level was still far higher than when
they were activated under Th2 conditions. In summary, the
overall level of Th1 commitment, as assessed by ICS, was not
significantly reduced in PSdko or PSRtko cells; however, we
observed a variable reduction (50–70%) in the magnitude of
IFN-c secretion from T cells deficient in presenilin compared to all
other T cells. These results suggest that an RBP-J independent
action of c-secretase is necessary to achieve maximal secretion of
IFNc from Th1 cells, independent of whether anti-CD3 or PMA/
Ionomycin were used for re-stimulation (Figure 5).
We also analyzed IL-4 secretion for these genotypes activated
under both Th1 and Th2 conditions (Figure 6). IL-4 was produced
by all genotypes of T cells selectively under Th2 conditions,
indicating that Th2 fate specification was intact in both presenilin-
deficient and RBP-J-deficient T cells. Further, RBP-J-deficient T
cells showed no significant differences in IL-4 production compared
to controls T cells from heterozygous littermates (Figure 6). Similar
to what we saw with IFN-c secretion by Th1 cells, IL-4 secretion
from PSdko T cells were somewhat reduced compared to controls.
Although this reduction was not statistically significant in compar-
ison to heterozygous littermates, it was statistically significant in
comparison with RBP-J deficient T cells (Figure 6A, B). Similar
reduction (,20–40%) was also seen in triple mutant PSRtko Tc e l l s .
Thus, we uncovered a general, RBP-J independent action of
presenilin or c-secretase that contributes to the magnitude of
cytokine secretion by differentiated Th1 and Th2 cells.
Discussion
Examples of Notch-dependent decisions in the hematopoietic
system includethe developmentof MarginalZone B cells [80,81,82],
multiple steps during T-cell development [63,83,84,85,86,87,88,
89,90,91], and vascular development (reviewed in [92]). In the
examples above, the dependence of the developmental decision on
Notch is similarly revealed independently of the experimental design
or genetic background. Due to the linearity of the Notch signaling
pathwayinvolvedinthesedecisions,theoutcomeofNotchinhibition
is not influenced by the step at which Notch inhibition occurs (e.g.,
ligand binding, c-secretase cleavage, association with RBP-J, or
assembly of the activation complex). In contrast, the contribution of
Notch signaling to peripheral T cell differentiation remains highly
controversial because different experimental approaches have
resulted instrikinglydifferentoutcomes(TableS1)[29].In particular,
the finding most difficult to reconcile with known mechanisms of
Notchactivation was thatspecificNotch ligandswere able to instruct
distinct T-helper fates [30]. These results were provocative because
they implied a mechanism of ‘‘ligand memory’’ by which different
ligands could produce distinct NICD activities in the nucleus.
This study tested the proposal of ‘‘ligand memory’’ by re-
creating artificial APCs that express functional Notch ligands
DLL1 and Jag1 that were previously suggested to instruct Th1 or
Th2 differentiation, respectively [30]. In our system, we provide
clear evidence verifying the ability of Notch ligands to activate
Notch-dependent transcription from one or more receptors.
Moreover, our controlled experiments were capable of detecting
a bias towards Th1 and Th2 differentiation when natural APCs
were used (Figure 2A, B). Despite that, neither DLL1 nor Jag1
could instruct or redirect T-helper fate specification in this assay.
Specifically, Notch1 and Notch2 activation occurred in response
to DLL1, yet DLL1 could not induce Th1 nor inhibit Th2
differentiation (Figure 2C). Surprisingly, we discovered that Jag1
was incapable of activating Notch1 in naı ¨ve CD4
+ T cells, most
likely due to the presence of Lfng in naı ¨ve CD4
+ T cells from
several genetic backgrounds (Figure 2D and unpublished data).
This finding further diminishes the likelihood that Jag1 plays a
significant role in Th2 differentiation through Notch1 activation
[71,93]. Although Jag1 could still activate Notch2 in the presence
of Lfng, previous studies indicated that NICD1, and not NICD2,
triggered robust Th2 responses (Amsen et al., 2003, Amsen et al.,
2007; Fang et al., 2007).
Some previous studies have induced Notch activation with
immobilized Notch ligands [31]. One caveat is that we cannot
directly compare the ‘‘level’’ of Notch activation produced by
APC-expressed ligands with those produced by immobilized
DLL1-Fc molecules [31]. Conceivably, higher levels of NICD
were achieved in the study by Maekawa [31], which titrated the
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the CD4
+ T cells. Regarding the discrepancy between APCs used
in different studies, it will be necessary to perform side-by-side
comparisons to resolve this apparent paradox.
Instead of identifying a mechanism of ‘‘ligand memory’’ capable
of instructing T-helper fate,we conclude that Notchis not capable of
inducing the initial steps towards fate acquisition. Rather, our data
suggestthatNotchcan,atmost,cooperatewithcytokinestooptimize
T-helper differentiation (Figure 2C & D), consistent with a co-
stimulatory role that has been suggested previously [59,60,78]. The
distinct transcriptional activities of NICD during Th1 or Th2
differentiation in vitro could be explained if accessibility to target gene
loci was influenced by a previous exposure to cytokine-induced
remodeling, independent of Notch ligands.
We find that removal of intact Notch signaling by targeted
deletion of Presenilins and/or RBP-J genes does not prevent
cytokine-induced Th1/Th2 fate specification (Figure 4, 5, 6). This
finding would be inconsistent with a genetic requirement for
Notch signaling during the initial fate selection. Since the T-helper
differentiation program is poised for rapid execution in response to
multiple cues, the choice of experimental system and the
‘‘strength’’ of the stimulus will impact the amplitude of the
contribution Notch makes. Our results suggest that intact Notch
signaling may act to allow cells to attain the maximum level of
commitment when insufficiently stimulated, highlighted by the
physiological requirement of RBP-J for optimal Th2 response in T
cells primed by parasite–exposed APC [56]. Although these
reports indicate that Notch signaling may augment GATA-3
transcription in vivo, they did not demonstrate a specific role for
Jagged in this process [56,57], nor did they ask if stronger T-cell
activation would bypass the need for Notch, as would be predicted
by a co-stimulatory function of Notch in this process.
The present study is one of a few studies that have compared the
effects of disrupting the Notch pathway during T-helper
differentiation at two independent positions in the pathway.
Importantly however, this is the only study that has performed
epistatic analysis of c-secretase and RBP-J deficiencies in this
system. As defective T cell expansion and cytokine production
were not observed in the absence of RBP-J alone, this epistatic
analysis has revealed unexpected RBP-J-independent (and perhaps
Notch-independent) functions of presenilins in regulating these
processes. One function, regulating optimal T cell expansion, was
reported by others [58,59]. Given that proliferation is necessary to
attain optimal T-helper differentiation [67,68,69,70], a defect in
proliferation may have led to the misinterpretation of c-secretase
function in T-helper cell specification. The second function,
observed under all the experimental conditions we deployed in this
study, contributes to the production or secretion of cytokines from
committed, differentiated T-helper cells. Since we have inactivated
c-secretase by deleting the Presenilin genes, one or both of the above
functions may reflect a protease-independent activity of presenilin
[94,95]. Distinguishing between these two presenilin activities will
require epistatic analyses with the other c-secretase components,
but that is beyond the scope of this study.
In summary, the data presented here are inconsistent with the
instructive role of Notch in Th1/Th2 fate specification. Instead,
separable functions of Notch and presenilin as genetic modifiers of
T-helper cell differentiation pathway(s) can account for the
dependence of published conclusions on genetic background and
experimental systems [29]. Despite clues pointing to TCR
activation as the pathway modified by Notch and/or presenilin
[74], this remains an important open question that will have to be
addressed experimentally.
Supporting Information
Figure S1 Characterization of the artificial APCs lines that
express Notch ligands (A) Expression of I-Ad and B7.1 on CHO
cells. CHOfNotch2 is a CHO line that stably expresses full-length
Notch2 receptor (Shimizu et al., 2000). CHO-I-Ad expresses I-Ad
MHC molecule but not B7.1 ligand. The APC parental line used
for the priming experiment contained both I-Ad & B7.1 molecules.
CHO-B7 (control line) was generated by infection with empty
GFP vector, CHO-DLL1 by infection with DLL1-ires-GFP-RV
construct, and CHO-Jag1 with Jagged1-ires-GFP-RV construct.
Left: Staining with PE-conjugated I-Ad antibody. Right: Staining
with PE-conjugated B7-1 antibody. X-axis is GFP signal. (B)
Luciferase assay with co-culture experiments indicates comparable
Notch ligand activity in our APCs lines. CHOfNotch2 cells was
transfected with TP1-luciferase and PCS2+bgal constructs for
24 h before co-culturing with different ligands expressing cells.
The fD1-CHO cell, a published line that exhibits functional ligand
activity (Shimizu et al., 2000), was used a positive control in the
experiment. (C) Cumulative number of viable T cells 7 days after
activation with different APC cells using 0.3 mM of Ova peptide in
either polarizing or non-polarizing conditions. Artificial APC lines
were treated with mitomycin C for 1 h prior to priming 0.56106
naı ¨ve CD4+ T cells. B7: CHO-IAD-B7; Dll1: CHO-IAD-B7-
DLL1; J1: CHO-IAD-B7-Jag1; & Spl: irradiated splenocytes from
BALB/c mice. Results are mean6SD from three independent
experiments.
Found at: doi:10.1371/journal.pone.0002823.s001 (6.95 MB TIF)
Figure S2 Notch ligands cannot instruct Th1/Th2 differentia-
tion but only enhance IFN-c and IL-4 production with inducing
cytokines. (A–C) The flow cytometry plots of three independent
experiments presented in Fig. 2A, B. Cells were gated on live
CD4+ T cells. Equal numbers of T cells were re-stimulated on Day
7 with PMA/Ionomycin for 4 h in the presence of Brefeldin A.
Intracellular cytokines staining were carried out using the
following antibodies: APC-conjugated INFc and PE-conjugated
anti-IL-4 antibodies were used for experiment 1; PE-conjugated
INFc and APC-conjugated anti-IL-4 antibodies were used for
experiment 2 and 3. Note that IL-4 ICS is highly variable and is
dependent on the types of conjugated antibodies used.
Found at: doi:10.1371/journal.pone.0002823.s002 (8.26 MB TIF)
Table S1 Proposed roles of Notch signaling in peripheral T cell
development. Table 1 summarized the proposed regulatory roles
of Notch signaling in T cell activation/proliferation (A) and Th1/
Th2 differentiation (B). The references are labeled with either
Arabic or Roman numeral to highlight their conflicting conclu-
sions regarding the functions of Notch in these processes.
Found at: doi:10.1371/journal.pone.0002823.s003 (0.08 MB
DOC)
Table S2 Summary of the level of IFN-c produced (A) Percent
of CD4+ T cells stained positive for intracellular IFN-c from three
independent APC-primed experiments described in Fig. 1 & 2.
The ICS values were presented as flow cytometry plot in
Supplemental Fig. 2A–C. The mean and standard deviation was
calculated using the percent of IFN-c positive cells and presented
graphically in Fig. 2A. (B) The level of IFN-c secreted by T cells
activated with various APCs lines under different polarizing
conditions. Equal numbers of T cells were re-stimulated on Day 7
with anti-CD3 for 24 hr. The supernatant was harvested and the
level of secreted cytokines was measured with ELISA.
Found at: doi:10.1371/journal.pone.0002823.s004 (0.08 MB
DOC)
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CD4+ T cells stained positive for intracellular IL-4 from three
independent APC primed experiments described in Fig. 1 & 2.
The ICS values were presented as flow cytometry plots in
Supplemental Fig. 2A–C. Note that the values of IL-4 ICS are
highly variable and are dependent on the types of conjugated
antibodies used. (B) The level of IL-4 secreted by T cells activated
with various APCs lines under different polarizing conditions.
ELISA of IL-4 was carried out as described in Supplemental Table
2B. The mean and standard deviation was calculated and
presented graphically in Fig. 2B.
Found at: doi:10.1371/journal.pone.0002823.s005 (0.07 MB
DOC)
Table S4 Cell expansion regimens used in the experiments (A)
CD4+ T cell passage regimen used for experiments described in
Figure 1 & 2. (B) CD4+ T cell passage regimen 2 where T cells
were expanded at a fixed time schedule regardless of their density
in culture. Individual data point was denoted as circle in Figure 3–
6. (C) CD4+ T cell passage regimen 3 where T cells were
expanded accordingly to their density in culture. Individual data
point was denoted as diamond in Figure 3–6. ‘‘Seed’’ stands for
the activation of naı ¨ve CD4+ T cells with anti-CD3/CD28
antibodies under Th1 or Th2 polarizing conditions. ‘‘#w’’ and
‘‘T#’’ denote the size of the culture flask. For example: 24w
denotes 24-well plate and T25 denotes T25 culture flask. ‘‘ReST’’
stands for re-stimulation.
Found at: doi:10.1371/journal.pone.0002823.s006 (0.06 MB
DOC)
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